Nick Lee Email & Phone Number

Marlborough, Ma, Us

Hologic, Inc. (Nasdaq: HOLX, S&P 500, ~$17B Market Cap, ~7k Employees) is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health.- Lead a team of 7 to deliver BSH (Breast and Skeletal Health) product management, application, and servicing effort to clients in China with a >$35M P&L and growing at a low-teens 5-yr CAGR- Build new functionalities such as competitive analysis and customer segmentation to offer more insights into China market as we move into a new economic landscape- Support on localization effort to assist in topline and bottomline goals

California, 94086, Us

Intuitive Fosun is a JV formed by Intuitive Surgical and Fosun Pharma.• Lead a 6-member team in overseeing upstream and downstream product marketing activities for the Da Vinci ecosystem, with a focus on new product launches, localization efforts, and competitive intelligence• Launch 2 advanced instruments (Vessel Sealer Extend and SureForm 45/60). Positioned for extended live instruments and domestic platform for portfolio expansion strategy and policy alignment initiatives• Execute and strategize various market related projects: end-of-life product transition, potential domestic new product development, VBP impact, and tender shaping

Miami Lakes, Fl, Us

• Spearhead a variety of deal activities including in-licensing and JV to enrich endovascular product portfolio offerings to Greater China region by exploring >10 partnerships and expanded 1 existing partnership• Developed and executed APAC corporate goals, collaborating with regional and global stakeholders to achieve immediate outcomes and meet company targets

Forchheim, De

(Corindus Vascular Robotics acquired by Siemens Healthineer for $1.1bn in Oct.2019)• Led upstream product development initiatives in collaboration with the R&D team to expand indications into the neuro-vascular field and ensure compatibility with the next-gen remote robotic platform• Conducted comprehensive market intelligence and engaged key opinion leaders (KOLs) to align product development goals with real-world practices and device partners across 3 vascular beds• Monitored market intelligence and technical advancements of more than 15 robotic surgical stakeholders to inform product strategy, competitive landscape analysis, and potential deal activities• Assisted in the NMPA (China FDA) regulatory process and expert meetings to facilitate regulatory approval in China and other clinical pilot initiatives.

Forchheim, De

• Led $50mn strategic JV partnerships (China-focused roadshow, term sheet, due diligence) with 4 potential strategic alliances and >10 investors to expand innovative interventional robotic technology into new markets• Developed and executed robust market forecasts, business intelligence, and financial modeling to support high-level strategic partnership decision-makingNYSE: CVRS

Boston, Massachusetts, Us

BHA serves multi-national medtech / life science companies on strategical and tactical engagements involving portfolio management, market access, and business development exercises. Selected client experience as below: • Partnered with multinational pharmaceutical and MedTech companies on strategic and tactical projects involving portfolio management, market access, due diligence, and business development• Conducted comprehensive market research and product portfolio assessments for a global imaging manufacturer, optimizing market and product segmentation• Identified and prioritized procedures and associated medical technologies to be added to a major international provider network within orthopedic, spine, and cardiac service lines

Durham, Nc, Us

Certificate: Healthcare Sector Management

Paris, France, Fr

• Built an ROI model reflecting the return of past marketing investments and served as future budget planning tool in rare disease department

Meyrin, Ch

• Analyzed and prioritized market access opportunities for 7 EMEA countries where Labatec aims to achieve 46% CAGR in the next five years

New Taipei, Tw

Led digital health platform strategy to increase international sales volume and accounts • Increased new international customer accounts through multiple engagements. Accounted for $10MM in annual sales with projected YoY growth of +10%• Reengaged inactive accounts through “solution selling”, e.g. providing new TeleHealth systems, serving as an invaluable business resource and providing value-added services to clients

• Managed global client accounts and successfully boosted company’s presence in several overseas markets, accounting for $2MM in annual sales• Relayed feedback from clients to research & development team and achieved 20% increase in customer satisfaction• Launched the first Myo-Electrical Hand (BeBionic) into Greater China market

Master Of Business Administration (Mba), Strategy | Healthcare Sector Management

Bachelor Of Science, School Of Biomedical Science And Engineering

Credit Courses, Human Medicine